Travere Therapeutics
TVTX
TVTX
129 hedge funds and large institutions have $1.1B invested in Travere Therapeutics in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 46 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.1% more ownership
Funds ownership: 102.26% → 103.36% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 46
Holders
129
Holding in Top 10
2
Calls
$9.96M
Puts
$1.37M
Top Buyers
| 1 | +$40.6M | |
| 2 | +$6.93M | |
| 3 | +$6.81M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.18M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$5.08M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$13.7M | |
| 3 | -$9.22M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$7.03M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$5.83M |